Holzapfel C, Cresswell L, Ahern AL, Fuller NR, Eberhard M, Stoll J, et al
A sensitivity analysis accounting for factors such as demographics, starting BMI classification, residence in a socially vulnerable area, comorbidities, and baseline HbA1c level also found that patients on GLP-1s were more likely to experience weight loss and to reduce their HbA1c levels
This means a person with high body fat will likely have a higher BAC than a lean, muscular person after consuming the same amount of alcohol
Cardiovascular Risks While some GLP-1 drugs improve heart health, patients with existing heart conditions require close monitoring
In this model, NO-related modulation may influence endothelial function and local microvascular stability